Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/24/2022
NMPA Suspends Import, Sales and Use of UCB's Epilepsy Drug Keppra
8/24/2022
Windtree Therapeutics Out-licenses Surfactant Platform in a $79M Globa...
8/24/2022
Four Publicly Traded Drugmakers Saw Huge Investments in July
8/23/2022
Hansoh Licenses Covid Drug Candidate GDI-4405 from GHDDI
8/22/2022
CDE Publishes the Annual Report on Chinese New Drug Registration Clini...
8/22/2022
Drug R&D and Approvals in China – July Update on YouTube (PharmCube)
8/22/2022
New Rational Drug Use Rules in China Benefit Pediatric, Anti-Tumor And...
8/19/2022
An Online Survey of Primary Care Physicians' Knowledge of Common Respi...
8/19/2022
Lundbeck Fails China Trial for CGRP Migraine Drug Vyepti, Undermining ...
8/19/2022
Pfizer Signs China Partnership to Make Paxlovid Covid Pills Locally
8/19/2022
Drug R&D and Product Registration News Digest August 2022 (3)
8/18/2022
Roche to Pay $60M Upfront in License Deal for Jemincare's Potential Pr...
8/18/2022
CDE Solicits Comments on the Draft "Technical Guidelines for Clinical ...
8/18/2022
17 Central Government Agencies Jointly Introduce New Incentives for Co...
8/18/2022
Kidney Disease Drugs A Hot Spot for July In-licensing (PharmaDJ)
8/18/2022
Vision 2028: How China Could Impact the Global Biopharma Industry (McK...
8/17/2022
Gilead to Acquire Remaining Worldwide Rights of Trodelvy from Everest ...
8/17/2022
AbbVie to Discontinue Phase 1 Trial for I-Mab's Anti-CD47 Therapy for ...
8/17/2022
Review of Chinese Biopharma Licensing Trends 2016-2021
8/17/2022
Review of Chinese Retail Drug Sales in Q1/2022
8/17/2022
Huadong Completes Acquisition of 35% Stake in Heidelberg Pharma
8/17/2022
Menarini and SciClone Enter License Pact for Vaborem in China for An...
8/17/2022
CDE Solicits Comments on the Draft "Technical Guidelines for Applicati...
8/17/2022
CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M10:...
8/17/2022
CDE Solicits Comments on the Draft "Guidelines for Communication of Re...
8/17/2022
WuXi STA Breaks Ground for 2nd Drug Manufacturing Facility in the U.S.
8/15/2022
BeiGene Enters Strategic Alliance with Ontada to Improve U.S. Communit...
8/15/2022
Chinese Pharma Cos Reportedly Slashing Headcount as Performance Dims
8/15/2022
July Sees More Pan-tumor Therapies Approved in China (PharmaDJ)
8/12/2022
Singaporean ADC Startup Axcynsis Therapeutics Establishes R&D Center i...
Page:
74
/
719
Total number of articles:
21546
:
[First]
[<<]
[72]
[73]
[74]
[75]
[76]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit